| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $33.5M | -15.0% |
| SG&A Expense | $15.8M | +30.5% |
| Operating Income | -$49.3M | +4.3% |
| Pre-tax Income | -$42.8M | +10.7% |
| Income Tax | -$64K | -113.3% |
| Net Income | -$42.8M | +10.8% |
| EPS (Basic) | -$0.32 | +31.9% |
| EPS (Diluted) | -$0.32 | +31.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.9M | -44.5% |
| Short-term Investments | $169.3M | +130.3% |
| Current Assets | $191.7M | +75.1% |
| Total Assets | $193.4M | +74.4% |
| Current Liabilities | $9.7M | -7.2% |
| Total Liabilities | $10.2M | -9.4% |
| Stockholders' Equity | $183.2M | +83.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.1M | -10.0% |
| Capital Expenditures | $12K | -65.7% |
| Investing Cash Flow | -$94.1M | -337.1% |
| Financing Cash Flow | $121.0M | +96.8% |
| Free Cash Flow | -$42.1M | -10.0% |